We used morphometry to compare tau load, defined as the sum of all tau positive lesions in the brain regions studied, between the two PSP groups and to determine the contribution of different neuronal and glial lesions to the tau pathology. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.